WGS Analysis of COVID-19 Positive Patients
Public ClinicalTrials.gov record NCT04353401. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Whole Genome Sequencing Analysis of of SARS-CoV-2 Positive Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
We aim to better understand the mode of action of COVID-19 in the context of its interaction with the host genome through whole-genome sequencing.
Study identification
- NCT ID
- NCT04353401
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 79 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2, 2020
- Primary completion
- Mar 8, 2022
- Completion
- Mar 8, 2022
- Last update posted
- Mar 21, 2024
2020 – 2022
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanda Investigational Site | Cleveland | Ohio | 44106 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Coronavirus Infection trials
Other public records listing Coronavirus Infection. Sorted by last update posted; newest first. Not a recommendation.
- NCT04885504: Post COVID-19 Biorepository Active, not recruiting
- NCT04367857: ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers Recruiting
- NCT04365101: Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04353401, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 21, 2024 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04353401 live on ClinicalTrials.gov.